ClinicalTrials.gg
TerminatedNCT02235753HITCAREUpdated Jan 24, 2017

High-intensity Exercise After Acute Cardiac Event (HITCARE)

An interventional study of High-intensity aerobic interval training, short interval and High-intensity aerobic interval training, long interval in Unstable Angina Pectoris, Acute Myocardial Infarction and Recurrent Myocardial Infarction, sponsored by Kuopio Research Institute of Exercise Medicine. Terminated at 1 site in Finland. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2017-01-24.

Sponsored by Kuopio Research Institute of Exercise Medicine · Not applicable, Interventional, and Treatment

Why this study was terminated
Recruitment was stopped due to lack of funding.
Phase
Not applicable
Study type
Interventional
Enrollment
27
Allocation
Randomized
Ages
40 Years to 80 Years
Sex
All
01

Study summary

Despite the well-known health benefits of physical exercise in the prevention of chronic diseases, less attention has been focused on the use of physical exercise as an essential part of good treatment for chronic disease. The aims of the study are to investigate the feasibility, medical effects, cost-effectiveness, and social perspectives of the individualized exercise-based rehabilitation [2 different high-intensity training (HIT) protocols combined with usual care (UC)] after acute coronary artery disease (CAD) event. The medical aim is to study mediating mechanisms of the physiological, biochemical and molecular effects of exercise training on the clinical outcomes. The aim of the health-economic evaluation is to assess the changes in the Health-Related Quality of Life (HRQL) and health care related costs for estimating the cost-effectiveness of HIT-based exercise rehabilitation. The purpose of the sociological analysis is to find out the social processes which make possible the emergence of the desired welfare effects.

Read the detailed description

The study population consists of patients living in the city of Kuopio or Siilinjarvi area in Eastern Finland, who have been treated in Kuopio University Hospital because of acute CAD event. After baseline measurements, the patients will be randomized into one of the 3 groups: short interval HIT protocol (HIT-S), long interval HIT protocol (HIT-L) or UC group. The intervention will be 12 months per patient and the expected duration of the whole study (intervention data collection) is estimated to be 4 years. In addition, all groups will have annual follow-up examinations scheduled up to 60 months after initiation of the intervention phase. The patients recruited for the study will be 750, a total of 250 patients per study group.

All measurements related to intervention will be performed at Kuopio Research Institute of Exercise Medicine. Examinations concerning myocardial structure and perfusion will be done at Turku PET Center (subsample).

The study complies with the Helsinki declaration, follows good clinical practice. Patient safety will follow normal medical practice. The intervention is not anticipated to cause health risks apart from the conventional treatment. All participants will be provided with diverse individualized information about their health and physical performance. The research methods employed in the study are safe. Physician and nurse will be present at each occasion when physically strenuous measurements are performed and careful provisions for appropriate first aid will be made. The measurements assessing cardiorespiratory and muscular fitness will involve hard effort and it is not unusual to feel innocent muscle pain for a few days after measurements demanding maximal effort. The other potential acute complications may include accidents (e.g. injuries due to slipping or falling) and medical emergencies like acute myocardial infarction.

Study hypotheses:

  1. Short (15 sec) and long interval (3 min) high-intensity aerobic interval training (HIT) combined with resistance training after acute CAD event are equally effective in improving cardiorespiratory fitness compared with UC.
  2. Despite higher unit costs, the differences in health-related quality of life effects are so large that both HIT interventions are cost-effective compared with UC.
  3. Patient's experiences and interpretation of HIT exercise as well as different social processes during rehabilitation explain the cost-effectiveness of the rehabilitation.
  4. Patient groups who will or will not benefit of HIT interventions can be identified and predicted.
02

Conditions studied

  • Unstable Angina Pectoris
  • Acute Myocardial Infarction
  • Recurrent Myocardial Infarction
03

In context

Angina, Unstable

282 studies on the registry are indexed under Angina, Unstable; 36 are open to participants now.

This study's enrollment of 27 is below the median of 180 across 177 interventional studies indexed under Angina, Unstable.

Browse Angina, Unstable studies →

Lead sponsor

This is the only study on the registry with Kuopio Research Institute of Exercise Medicine as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • hospital care after acute CAD event (ICD-10 codes I20.0-I22)
  • age 40-80 years
  • signed informed consent form

Exclusion criteria

Exclusion Criteria:

  • conditions preventing regular exercise training
  • severe/malignant disease (life expectancy \<12 months)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
27 participants (actual)

Study arms

  • Experimental
    High-intensity interval training, HIT-S

    High-intensity aerobic interval training, short interval (HIT-S)

    Behavioral: High-intensity aerobic interval training, short interval

  • Experimental
    High-intensity interval training, HIT-L

    High-intensity aerobic interval training, long interval (HIT-L)

    Behavioral: High-intensity aerobic interval training, long interval

  • No intervention
    Usual care

    control group

Interventions

  • BehavioralHigh-intensity aerobic interval training, short interval

    The intensity of HIT-S sessions (cycle ergometer) will be increased during 3 to 6 months from 60% of VO2peak to 100% which will be the target intensity from 6 to 12 months. The protocol includes four 6 min sets consisting of 15 sec exercise followed by 15 sec passive recovery separated with 3 min passive recovery between sets. Exercise session will last ca. 40 min, with 12 min of HIT, warm-up and recovery. The intensity of the 15 seconds exercise bouts will be based on VO2peak at baseline and after 6 months. Meanwhile, the estimated VO2peak from the submaximal test will be used to adjust the training intensity in HIT sessions. Training will be conducted in a group of 1-3 HIT-S patients with ECG monitoring and supervised by physician.

  • BehavioralHigh-intensity aerobic interval training, long interval

    The intensity of HIT-L sessions (cycle ergometer) will be increased during 3 to 6 months from 60% of VO2peak to 90% which will be the target intensity from 6 to 12 months. The protocol includes four 3 min exercise bouts with a 4 min recovery (pedaling at 0 W) between bouts. Exercise session will last ca. 40 min, with 12 min of HIT, warm-up and recovery. The intensity of the 3 min exercise bouts will be based on VO2peak at baseline and after 6 months. Meanwhile, the estimated VO2peak from the submaximal test will be used to adjust the training intensity in HIT sessions. Training will be conducted in a group of 1-3 HIT-L patients with ECG monitoring and supervised by physician.

06

What researchers measure

Primary outcomes

  1. Change in cardiorespiratory fitness as assessed by peak oxygen uptake (VO2peak)

    Time frame: Baseline, 6 and 12 months

Secondary outcomes

  1. Incremental health care cost/quality-adjusted life-year-relation

    Time frame: Baseline, 6 and 12 months

  2. Social processes explaining adherence and motivation to exercise rehabilitation

    Social analysis will be performed by specific questionnaires and interviews. Subjective perceptions on the social mechanisms impacting on health and well-being as a part of the rehabilitation processes will be also be modelled using comparative causal mapping techniques (CMT) (See http://www.uef.fi/fi/cmap3).

    Time frame: Baseline, 6 and 12 months

  3. Total costs of the use of health care services

    The use of total health services will be assessed by diary, questionnaire and from registers (national, hospital district and domicile health center).

    Time frame: Baseline, 6 and 12 months

  4. Utilization of health care resources

    Time frame: Baseline, 6 and 12 months

  5. Change in health-related quality of life

    Time frame: Baseline, 6 and 12 months

Other outcomes

  1. Change in ergospirometer variables

    Time frame: Baseline, 6 and 12 months

  2. Change in muscular performance

    Time frame: Baseline, 6 and 12 months

  3. Change in daily energy expenditure

    Time frame: Baseline, 6 and 12 months

  4. Sleeping time

    Time frame: Baseline, 6 and 12 months

  5. Sitting time

    Time frame: Baseline, 6 and 12 months

  6. Dietary habits

    Measured by food frequency questionnaire

    Time frame: Baseline, 6 and 12 months

  7. Change in chest pain symptoms, exercise induced angina or ischemia

    Composite measure based on anamnesis and ECG

    Time frame: Baseline, 6 and 12 months

  8. Change in antianginal and other medication

    Time frame: Baseline, 6 and 12 months

  9. Hospitalization due to cardiovascular causes

    Time frame: Baseline, 6 and 12 months

  10. Change in vascular risk factors

    Time frame: Baseline, 6 and 12 months

  11. Progression of peripheral atherosclerosis

    Time frame: Baseline, 6 and 12 months

  12. Change in cognitive function

    Time frame: Baseline and 12 months

  13. Change in depressive symptoms

    Time frame: Baseline, 6 and 12 months

  14. Intervention related adverse events

    Time frame: Throughout the intervention phase

  15. Change in myocardial blood flow capacity and left ventricular function

    Time frame: Baseline and 12 months

  16. Change in myocardial blood flow at rest and during adenosine infusion

    Time frame: Baseline and 12 months

  17. Change in myocardial blood flow reserve

    Time frame: Baseline and 12 months

  18. Change in left ventricular ejection fraction

    Time frame: Baseline and 12 months

  19. Change in left ventricular longitudinal peak systolic strain

    Time frame: Baseline and 12 months

  20. Change in left mitral annular diastolic tissue velocity

    Time frame: Baseline and 12 months

  21. Change in autonomic nervous system control of cardiac function

    Time frame: Baseline and 12 months

  22. Change in body composition

    Measured by bioimpedance

    Time frame: Baseline, 6 and 12 months

  23. Change in anthropometric measures

    Measured by body weight, body height, waist circumference, and hip circumference. Body mass index and waist to hip ratio will be calculated.

    Time frame: Baseline, 6 and 12 months

  24. All-cause death

    Time frame: Baseline, 6 and 12 months; annual follow-up up to 60 months

  25. Cardiovascular death

    Time frame: Baseline, 6 and 12 months; annual follow-up up to 60 months

07

Study locations

1 site
  • Kuopio Research Institute of Exercise Medicine
    Kuopio, 70100, Finland
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 24, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02235753
Lead sponsor
Kuopio Research Institute of Exercise Medicine
Collaborators
Social Insurance Institution, Finland, Kuopio University Hospital, University of Eastern Finland, University of Basel
Responsible party
Rainer Rauramaa (Professor, Kuopio Research Institute of Exercise Medicine) — Principal investigator
First posted
Sep 10, 2014
Start date
Dec 2014
Primary completion
Nov 14, 2016
Completion
Dec 2019 (estimated)
Last update
Jan 24, 2017

Study contacts

Rainer Rauramaa, professor
principal investigator · Kuopio Research Institute of Exercise Medicine

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion